All news

Editas Medicine (EDIT) Projected to Announce Earnings on Monday

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Editas Medicine (EDIT) is expected to report its Q3 2026 earnings before market open on Monday, November 9th, with analysts forecasting a loss of $0.21 per share and revenue of $4.54 million. The company's earnings call is scheduled for November 10th at 4:00 p.m. ET.

Read original source

EDIT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.